[go: up one dir, main page]

AU2746397A - Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers - Google Patents

Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers

Info

Publication number
AU2746397A
AU2746397A AU27463/97A AU2746397A AU2746397A AU 2746397 A AU2746397 A AU 2746397A AU 27463/97 A AU27463/97 A AU 27463/97A AU 2746397 A AU2746397 A AU 2746397A AU 2746397 A AU2746397 A AU 2746397A
Authority
AU
Australia
Prior art keywords
diethanolamides
fatty acids
transdermal administration
steroid hormones
permeation enhancers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27463/97A
Inventor
Charles D. Ebert
Venkateshwaran Srinivasan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Laboratories UT Inc
Original Assignee
Theratech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theratech Inc filed Critical Theratech Inc
Publication of AU2746397A publication Critical patent/AU2746397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU27463/97A 1996-04-30 1997-04-29 Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers Abandoned AU2746397A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64037196A 1996-04-30 1996-04-30
US08640371 1996-04-30
PCT/US1997/007104 WO1997040792A1 (en) 1996-04-30 1997-04-29 Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers

Publications (1)

Publication Number Publication Date
AU2746397A true AU2746397A (en) 1997-11-19

Family

ID=24567978

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27463/97A Abandoned AU2746397A (en) 1996-04-30 1997-04-29 Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers

Country Status (3)

Country Link
AU (1) AU2746397A (en)
WO (1) WO1997040792A1 (en)
ZA (1) ZA973749B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6603751B1 (en) 1998-02-13 2003-08-05 Qualcomm Incorporated Method and system for performing a handoff in a wireless communication system, such as a hard handoff
US20030194033A1 (en) 1998-05-21 2003-10-16 Tiedemann Edward G. Method and apparatus for coordinating transmission of short messages with hard handoff searches in a wireless communications system
US6587446B2 (en) 1999-02-11 2003-07-01 Qualcomm Incorporated Handoff in a wireless communication system
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
MX2009013305A (en) * 2007-06-06 2010-04-21 Univ Chile Pharmaceutical composition of a new system for vaginal release of steroids.
US8964692B2 (en) 2008-11-10 2015-02-24 Qualcomm Incorporated Spectrum sensing of bluetooth using a sequence of energy detection measurements

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560922A (en) * 1986-05-30 1996-10-01 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
EP0399432B1 (en) * 1989-05-25 1994-06-22 Takeda Chemical Industries, Ltd. Transdermal therapeutic composition
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
US5314694A (en) * 1990-10-29 1994-05-24 Alza Corporation Transdermal formulations, methods and devices
US5460820B1 (en) * 1993-08-03 1999-08-03 Theratech Inc Method for providing testosterone and optionally estrogen replacement therapy to women
US5554381A (en) * 1993-08-09 1996-09-10 Cygnus, Inc. Low flux matrix system for delivering potent drugs transdermally

Also Published As

Publication number Publication date
WO1997040792A1 (en) 1997-11-06
ZA973749B (en) 1998-04-01

Similar Documents

Publication Publication Date Title
AU3654697A (en) Transdermal application of naturally occurring steriod hormones
AU7998187A (en) Transdermal administration of progesterone, estradiol esters, and mixtures thereof
AU2472997A (en) A novel composition for transdermal administration of an estrogen, a progestin or a mixture thereof
AU3231300A (en) Sitostanol formulation with emulsifier to reduce cholesterol absorption and method for preparing and use of same
AU3008997A (en) Antagonists of gonadotropin releasing hormone
AU4745390A (en) Compositions for transdermal delivery of estradiol
CA2012875A1 (en) Skin permeation enhancer compositions
AU6333499A (en) Use of nanoscale sterols and sterol esters
AU4209400A (en) Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
AU3071397A (en) Antagonists of gonadotropin releasing hormone
IE894108L (en) Sulfonic acid substituted aromatic steroids as inhibitors of¹steroid 5ó-reductase
AU1865199A (en) Composition and method for dermal and transdermal administration of a cytokine
AU2922797A (en) Novel steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
PL345695A1 (en) Estradiol-containing patch for transdermal administration of hormones
AU2078197A (en) Method of folding and using static charge to align and retain folded mater ial
AU7358800A (en) Compositions and methods for modification of skin lipid content
AU3141197A (en) Antagonists of gonadotropin releasing hormone
AU1262501A (en) Compositions for transdermal and transmucosal administration of therapeutic agents
AU2746397A (en) Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers
AU1429697A (en) Systems and methods for the transdermal administration of androgenic agents
EP0776904A3 (en) Method for the preparation of steroid derivative ketal
CA2258681A1 (en) Process for the preparation of 17-esters of 9.alpha.,21-dihalo-pregnane-11.beta.,17.alpha.diol-20-ones
AU5155198A (en) Method and composition for transdermal administration of pharmacologic agent
AU3869399A (en) Transdermal administration of fenoldopam
AU6335998A (en) Method for reducing secretion of apolipoprotein b in animals by administering conjugated linoleic acid